Oral Biolife Inc.
PrivateLast Round
Series A
Mar 6, 2026
Total Funding Raised
$200,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oral Biolife Inc. operates in Healthcare & Life Sciences and is based in Bethlehem, Pennsylvania. Its latest recorded funding round was a Seed round in October 2025.
Oral Biolife Inc. is a biotechnology company that develops dental therapeutics, including its lead asset Ambrilux Dental Gel, designed for the treatment of periodontal disease through bone regeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oral Biolife Inc. Comparables
Compare Oral Biolife Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioChange | 80% | |
| HysensBio | 76% | |
| Geistlich Pharma | 69% |
For institutional investors. Book with your work email.
Oral Biolife Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 6, 2026 | ||||
| Seed | Oct 15, 2025 | ||||
| VC Round | Jun 24, 2025 | ||||
| Grant | Jan 25, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oral Biolife Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 6, 2026
$10M round completed.
- May 2, 2025
Monthly visitors grew 36% MoM, reaching 1.5K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 12, 2026
Oral Biolife Inc. is developing its lead human product, Ambrilux(TM) Dental Gel, which is in clinical development for periodontal bone regeneration.
For institutional investors. Book with your work email.
Oral Biolife Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oral Biolife Inc.'s valuation, stock price, and market status.
Is Oral Biolife Inc. a public or private company?
Oral Biolife Inc. is a private company.
What is the current stock price of Oral Biolife Inc.?
Oral Biolife Inc. is a private company, so its shares have no public market price. Caplight tracks Oral Biolife Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oral Biolife Inc. worth (valuation)?
Valuation information for Oral Biolife Inc. is not publicly available.
Can I buy Oral Biolife Inc. stock?
Oral Biolife Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oral Biolife Inc.'s last funding round?
Oral Biolife Inc.'s most recent funding round was Series A on March 6, 2026.
Who are the main investors in Oral Biolife Inc.?
Key investors in Oral Biolife Inc. include Benjamin Franklin Technology Partners.
Will Oral Biolife Inc. IPO soon?
No public IPO plans have been announced for Oral Biolife Inc..
How can I track Oral Biolife Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Oral Biolife Inc.'s shares on secondary markets.